TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30753371

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25693011

Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 14215

Group type: COMPARATOR
Intervention: qHPV vaccine
Number of subjects: 14215
Study: 22991337

Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 243

Group type: COMPARATOR
Intervention: Cerclage
Number of subjects: 243
Study: 22090182

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal balloon angioplasty (PTA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Primary stenting (balloon expandable stent)
Number of subjects: 54
Study: 19531899

Group type: EXPERIMENTAL
Intervention: Pitavastatin (2 mg/day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 160
Study: 16464810

Group type: EXPERIMENTAL
Intervention: Intensive pharmaceutical care campaign targeting inappropriate use of triptans
Number of subjects: 2463

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 2463
Study: 14725513

Group type: EXPERIMENTAL
Intervention: Esmolol (1mg x kg(‐1) bolus, followed by an infusion at 250 microg x kg(‐1)min(‐1))
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam (0.04 mg x kg(‐1))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 60
Study: 11328905

Group type: EXPERIMENTAL
Intervention: Dalteparin (initial dose reduced to 50% if no clotting observed, approximately 5000 IU IV)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (pre-dialytic patients)
Number of subjects: 12
Study: 10495794

Group type: EXPERIMENTAL
Intervention: Cyclosporine alone (monotherapy)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Cyclosporine plus steroids (double therapy)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Cyclosporine plus steroids plus azathioprine (triple therapy)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Switched from monotherapy to double or triple therapy
Number of subjects: 354

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 354

Group type: COMPARATOR
Intervention: Double therapy
Number of subjects: 354

Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 354
Study: 7956701

Group type: EXPERIMENTAL
Intervention: Radical mediastinal lymph node dissection (average 11.5 nodes dissected)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (dissected only suspected metastatic lymph nodes, average 3.4 nodes)
Number of subjects: 225
Study: 3802437

Group type: EXPERIMENTAL
Intervention: Postural hypotension (Group 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other groups (Group 2, 3, and 4)
Number of subjects: 0
Study: 31841577

Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir, 5 mg/kg, 3 times daily for 14 days
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 29436401

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional phacoemulsification surgery (CPS)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Hypothetical 3:1 model
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Hypothetical 4:1 model
Number of subjects: 400
Study: 26989818

Group type: EXPERIMENTAL
Intervention: Manipulation and massage
Number of subjects: 105

Group type: COMPARATOR
Intervention: Massage only (control)
Number of subjects: 105
Study: 25082852

Group type: COMPARATOR
Intervention: No additional preparation (Group 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Commercial high-fat solution containing 43.8 g of lipids (Group 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 50 mL of olive oil (Group 3)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Verapamil (Group 4)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: cFFA levels
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: cFFA level (cutoff value)
Number of subjects: 36
Study: 23259261

Group type: EXPERIMENTAL
Intervention: Spinal balancing intervention (acu-puncture and Tuina applied to specific points)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional acupuncture (applied to local points and affected meridians)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Spinal balancing intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 120
Study: 21083721

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 69

Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 69
Study: 18480694

Group type: EXPERIMENTAL
Intervention: Mecamylamine hydrochloride (MEC) up to 10 mg/d; n = 11
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PLO); n = 10
Number of subjects: 21
Study: 15746684

Group type: EXPERIMENTAL
Intervention: Transvaginal assessment of fetal head station using a birth simulator
Number of subjects: 57
Study: 11210400

Group type: EXPERIMENTAL
Intervention: Oxybutynin XL 15 mg (fed treatment)
Number of subjects: 0
Study: 9611701

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) only
Number of subjects: 596

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: CEE combined with progestins
Number of subjects: 596
Study: 7801420

Group type: EXPERIMENTAL
Intervention: Oral oestrogen therapy (ethinyl oestradiol 1 mg daily for 2 weeks, then 150 micrograms; intramuscular polyoestradiol phosphate 160 mg monthly for 3 months, then 80 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Surgical castration (orchidectomy)
Number of subjects: 100
Study: 2971184

Group type: EXPERIMENTAL
Intervention: RU 41740
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 29667290

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg thrice daily for 52 months
Number of subjects: 390

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study: 27367242

Group type: EXPERIMENTAL
Intervention: fMRI-guided surgery
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard microsurgery (control group)
Number of subjects: 184
Study: 23266255

Group type: EXPERIMENTAL
Intervention: 1% menthol inhalation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 0.5% menthol inhalation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (saline with 0.05% menthol)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (15 subjects)
Number of subjects: 14
Study: 22256165

Group type: EXPERIMENTAL
Intervention: 2 hour turning intervals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 hour turning intervals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 hour turning intervals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabor filter technique
Number of subjects: 0
Study: 19166870

Group type: EXPERIMENTAL
Intervention: Verb primes located in a remote position
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remote primes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic relations
Number of subjects: 0
Study: 16723313

Group type: EXPERIMENTAL
Intervention: Object alternation task
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Spatial stimulus-response incompatibility task
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Gambling task
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Response times in object alternation task
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 29
Study: 14966713

Group type: EXPERIMENTAL
Intervention: Balance rehabilitation with visual cue deprivation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Balance rehabilitation with free vision
Number of subjects: 20
Study: 11305509

Group type: EXPERIMENTAL
Intervention: Loxiglumide (10 mg/kg i.v.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Loxiglumide in H. pylori-eradicated subjects
Number of subjects: 10
Study: 9631991

Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly for 4 months
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly for 6 months
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly for 9 months
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study: 10150183

Group type: EXPERIMENTAL
Intervention: Trapidil (T) 100 mg t.i.d.
Number of subjects: 360

Group type: COMPARATOR
Intervention: Aspirin (ASA) 100 mg t.i.d.
Number of subjects: 360
Study: 2566707

Group type: EXPERIMENTAL
Intervention: Carteolol 2% (20 eyes)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Metipranolol 0.6% (20 eyes)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Oxybuprocain 0.4% (10 eyes)
Number of subjects: 35

Group type: COMPARATOR
Intervention: NaCl 0.9% (20 eyes)
Number of subjects: 35
Study: 31087150

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency clamp (BRC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Plasma blade (PB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cold dissection (CD)
Number of subjects: 50
Study: 27929203

Group type: EXPERIMENTAL
Intervention: Prasugrel (0.08 mg/kg/day)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study: 25280140

Group type: EXPERIMENTAL
Intervention: Rigid flexible laryngoscope (RIFL)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Fiberoptic bronchoscope (FOB)
Number of subjects: 41
Study: 23467248

Group type: EXPERIMENTAL
Intervention: Hybrid stabilization using DIAM
Number of subjects: 75

Group type: COMPARATOR
Intervention: PLIF
Number of subjects: 75
Study: 21351082

Group type: EXPERIMENTAL
Intervention: 5-ALA
Number of subjects: 370

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study: 19781044

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) plus anterior repair
Number of subjects: 56

Group type: COMPARATOR
Intervention: Colposuspension
Number of subjects: 56
Study: 15880334

Group type: EXPERIMENTAL
Intervention: Tolvaptan 30 mg/day
Number of subjects: 2260

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 2260
Study: 15152493

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (low dose aspirin 75 to 150 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin plus clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 0
Study: 12579659

Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac sodium (DS) eyedrops
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 70
Study: 7601080

Group type: EXPERIMENTAL
Intervention: 200mg oral iodized oil
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 400mg oral iodized oil
Number of subjects: 110
Study: 2564763

Group type: EXPERIMENTAL
Intervention: Flurazepam (15 mg)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Temazepam (15 mg)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 70935

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (Cyklokapron)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31706292

Group type: EXPERIMENTAL
Intervention: Very Early Supported Discharge (VESD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordinary discharge routine (Control)
Number of subjects: 0
Study: 28531241

Group type: EXPERIMENTAL
Intervention: Pravastatin sodium (40 mg/d)
Number of subjects: 2867

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 2867
Study: 26132941

Group type: EXPERIMENTAL
Intervention: Afamelanotide (16 mg subcutaneous implant every 60 days)
Number of subjects: 168
Study: 23634822

Group type: EXPERIMENTAL
Intervention: Vaccine (CAF01-adjuvanted HIV-1 peptides)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 20950305

Group type: EXPERIMENTAL
Intervention: Biopsy performed (n=11,721)
Number of subjects: 50194

Group type: EXPERIMENTAL
Intervention: No biopsy performed (n=1,238)
Number of subjects: 50194

Group type: COMPARATOR
Intervention: Screening-positive men (biopsied and non-biopsied)
Number of subjects: 50194
Study: 17614012

Group type: EXPERIMENTAL
Intervention: Loaded squat jumps
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Maximal voluntary isometric knee extension contractions (MVC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: EMG and antagonist co-activation during MVC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Neuromuscular efficiency during MVC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Neuromuscular efficiency during submaximal voluntary isometric knee extension contractions (MVC40)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Agonist and antagonist activity during MVC
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MVC40
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Overall strength and power
Number of subjects: 32
Study: 16987435

Group type: EXPERIMENTAL
Intervention: Probiotic product containing Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard yogurt containing Lactobacillus delbrueckii sp. bulgaricus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dietary deprivation of fermented foods
Number of subjects: 0
Study: 12779020

Group type: EXPERIMENTAL
Intervention: Tinidazole 500 mgs (OCT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metronidazole 400 mgs (OCM)
Number of subjects: 100
Study: 10968436

Group type: EXPERIMENTAL
Intervention: Experimental treatments
Number of subjects: 136

Group type: COMPARATOR
Intervention: Standard treatments
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Non-profit funded studies
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Profit-making funded studies
Number of subjects: 136
Study: 9181163

Group type: EXPERIMENTAL
Intervention: Sequestration of one unit of fresh autologous blood (5-8 ml/kg); Group I
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sequestration of two units of fresh autologous blood (12-15 ml/kg); Group II
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (Group III)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-volume phlebotomy (Group II)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Low-volume phlebotomy (Group I)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 42
Study: 1492432

Group type: EXPERIMENTAL
Intervention: Synchronized coronary venous retroperfusion (SRP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No SRP
Number of subjects: 26
Study: 3903781

Group type: EXPERIMENTAL
Intervention: Factor XIII
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 29549016

Group type: EXPERIMENTAL
Intervention: Herbert bone screw (HBS)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Lag screw (LS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Miniplate (MP)
Number of subjects: 21
Study: 28451956

Group type: EXPERIMENTAL
Intervention: Short term psychodynamic psychotherapy (STPP)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance as rated by patients
Number of subjects: 47

Group type: COMPARATOR
Intervention: Therapeutic alliance as rated by therapists
Number of subjects: 47
Study: 25610916

Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Manual toothbrush + Persica mouthwash
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Manual toothbrush + chlorhexidine mouthwash
Number of subjects: 72

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 72
Study: 22487908

Group type: EXPERIMENTAL
Intervention: Powered endoscopic instruments
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional endoscopic instruments
Number of subjects: 200
Study: 21619701

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) injections at a pharmacologic dose of 0.3 mg/kg/week
Number of subjects: 34

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 34
Study: 18622302

Group type: EXPERIMENTAL
Intervention: Group A (younger patients)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Group B (older patients)
Number of subjects: 260
Study: 16118650

Group type: EXPERIMENTAL
Intervention: 50 mg vitamin C supplementation
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: 500 mg vitamin C supplementation
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 244
Study: 14501606

Group type: EXPERIMENTAL
Intervention: Ospemifene 90 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ospemifene 60 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ospemifene (all doses)
Number of subjects: 160
Study: 11740194

Group type: EXPERIMENTAL
Intervention: Whey protein (PRO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise (PRE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined treatment (PRO-PRE)
Number of subjects: 30
Study: 9757959

Group type: EXPERIMENTAL
Intervention: Intramuscular methotrexate 50 mg/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intramuscular methotrexate 60 mg/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intramuscular methotrexate (both dosages)
Number of subjects: 20
Study: 8158515

Group type: EXPERIMENTAL
Intervention: CalCarb graft material
Number of subjects: 20

Group type: COMPARATOR
Intervention: DEBR (open flap debridement)
Number of subjects: 20
Study: 3145557

Group type: EXPERIMENTAL
Intervention: recombinant tissue plasminogen activator (rt-PA)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: streptokinase i.v.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: thrombolytic therapy (overall)
Number of subjects: 72
Study: 29480253

Group type: EXPERIMENTAL
Intervention: Toric IOL with a capsular tension ring (CTR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Toric IOL without a capsular tension ring (CTR)
Number of subjects: 50
Study: 28401417

Group type: EXPERIMENTAL
Intervention: Comprehensive educational program (public lectures, instructional brochures, case videos, simulations, role-playing)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Conventional oral education (control group)
Number of subjects: 220
Study: 25973985

Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 58
Study: 23311722

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 21881932

Group type: EXPERIMENTAL
Intervention: Sevoflurane-lidocaine-tourniquet (SLT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevoflurane (S)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lidocaine (L)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevoflurane-lidocaine (SL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lidocaine-tourniquet (LT)
Number of subjects: 100
Study: 19085261

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg/day
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 83
Study: 16831981

Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide (Nt-proBNP)
Number of subjects: 3199

Group type: EXPERIMENTAL
Intervention: Soluble intercellular adhesion molecule-1
Number of subjects: 3199

Group type: EXPERIMENTAL
Intervention: Microalbuminuria
Number of subjects: 3199

Group type: EXPERIMENTAL
Intervention: Soluble interleukin-1 receptor antagonist
Number of subjects: 3199

Group type: EXPERIMENTAL
Intervention: Fibrinogen
Number of subjects: 3199
Study: 12624579

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise group (LEX; 50% 1-repetition maximum; 13 repetitions per exercise)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: High-intensity exercise group (HEX; 80% 1-repetition maximum; eight repetitions per exercise)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 10587386

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 66
Study: 9590863

Group type: EXPERIMENTAL
Intervention: Diamox administered preoperatively
Number of subjects: 58

Group type: COMPARATOR
Intervention: Mannitol or no drugs administered preoperatively
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Postoperative IOP measurements
Number of subjects: 58
Study: 1920306

Group type: EXPERIMENTAL
Intervention: Early treatment with SAARD therapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Delayed initiation of SAARD therapy
Number of subjects: 83
Study: 6122937

Group type: EXPERIMENTAL
Intervention: Sotalol 320 mg once daily
Number of subjects: 1456

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: Beta adrenoceptor blocking drugs
Number of subjects: 1456
Study: 30519893

Group type: EXPERIMENTAL
Intervention: Cefuroxime bolus-continuous infusion targeting free serum cefuroxime concentrations of 64 mg/L
Number of subjects: 196

Group type: COMPARATOR
Intervention: Standard bolus dose of cefuroxime (1.5 g bolus dose four-hourly)
Number of subjects: 196
Study: 28120603

Group type: EXPERIMENTAL
Intervention: High-dose nebulized budesonide (1 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic steroid therapy (prednisolone 0.5 mg/kg iv three times daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose nebulized budesonide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic steroid therapy
Number of subjects: 0